Equivalent in mechanism to existing evidence that RING-type E3 ligases TRIM56 and RNF208 perform tumor-suppressive functions through ubiquitination-dependent negative regulation of Vimentin [11, 12], we identify HRD1 as an emerging member of those RING E3 enzymes pivotal in cancer progression for the first time. This evidence concerns the gene RNF208 and neoplasm.